Medical Marijuana News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

05.04.17	Por Grace Foundation Announces Publication of Positive Independent Study Results in Mexico Using RSHO-X™ (PR Newswire)
05.04.17	Por Grace Foundation annonce la publication des résultats positifs d'une étude indépendante avec RSHO-X™ effectuée au Mexique (PR Newswire)
05.04.17	Por Grace Foundation Announces Publication of Positive Independent Study Results in Mexico Using RSHO-X™ (PR Newswire)
04.04.17	Medical Marijuana, Inc. Announces Sponsorship and Participation at 5th Annual Americans for Safe Access Unity Conference in D.C. (PR Newswire)
04.04.17	Legal Cannabis Market Continues to Show Support (PR Newswire)
30.03.17	Medical Marijuana, Inc. Subsidiary HempMeds® Brasil To Hold Country's First-Ever Symposium On Medical Cannabis For Health Professionals (PR Newswire)
30.03.17	Legal Cannabis Market is Rapidly Developing (PR Newswire)
29.03.17	Le principal investissement de Medical Marijuana, Inc. AXIM Biotech signe un accord sur les conditions et modalités avec la société d'API américaine pour développer un produit bioéquivalent au Marinol (PR Newswire)
28.03.17	AXIM Biotech, ein Investmentunternehmen von Medical Marijuana, Inc., unterzeichnet Term Sheet Agreement mit US-amerikanischem API-Hersteller, um einen Bio-Ersatz für Marinol zu entwickeln (PR Newswire)
28.03.17	Medical Marijuana, Inc. Major Investment AXIM Biotech Enters Term Sheet Agreement With U.S. API Company To Develop Bioequivalent Product To Marinol (PR Newswire)
28.03.17	Medical Marijuana, Inc. Major Investment AXIM Biotech Enters Term Sheet Agreement With U.S. API Company To Develop Bioequivalent Product To Marinol (PR Newswire)
28.03.17	Cannabis Patients, Advocates, and Industry Leaders Converge at National Medical Cannabis Unity Conference in D.C. (PR Newswire)
28.03.17	High Quality Cannabis Extracts (CBD) Continues to Thrive With Rising Demand (PR Newswire)
28.03.17	High Quality Cannabis Extracts (CBD) Continues to Thrive With Rising Demand (PR Newswire)
24.03.17	The Legal Cannabis Market Maintains Growth (PR Newswire)
22.03.17	Mixed Marijuana Messages From Trump Administration Make Diversification Imperative (PR Newswire)
21.03.17	Medical Marijuana, Inc. Investment AXIM Biotech Retains Ora To Manage Upcoming Product Development And Clinical Trials On Glaucoma And Dry Eye Indications (PR Newswire)
21.03.17	The Demand for Legal Cannabis Products are Increasing (PR Newswire)
17.03.17	The Data Surrounding the Legal Cannabis Markets (PR Newswire)
16.03.17	Advanced Extraction Methods Leading to High Quality CBD Products and Revenue Growth Potential (PR Newswire)
16.03.17	Advanced Extraction Methods Leading to High Quality CBD Products and Revenue Growth Potential (PR Newswire)
15.03.17	Increasing Jobs in the Legal Cannabis Market (PR Newswire)
15.03.17	Medical Marijuana, Inc. Welcomes New Sales Manager Eric Raszewski to Subsidiary HempMeds® Team (PR Newswire)
14.03.17	Studienergebnisse: Tochtergesellschaft von Medical Marijuana, Inc., HempMeds® Mexico, kündigt Veröffentlichung einer Studie zur Verwendung ihres Real Scientific Hemp Oil-X™ zur Behandlung von... (PR Newswire)
14.03.17	Resultats d'une etude : la filiale de Medical Marijuana, Inc. , HempMeds® Mexico, annonce la publication d'une etude portant sur son produit Real Scientific Hemp Oil-X™ dans le traitement de... (PR Newswire)
14.03.17	Study Results: Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Announces Release Of Study Using Its Real Scientific Hemp Oil-X™ To Treat Epileptic Children (PR Newswire)
14.03.17	Study Results: Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Announces Release Of Study Using Its Real Scientific Hemp Oil-X™ To Treat Epileptic Children (PR Newswire)
14.03.17	Biotech Influence in Exploding Cannabis Industry Boosting Innovative Treatments and Therapies (PR Newswire)
14.03.17	Biotech Influence in Exploding Cannabis Industry Boosting Innovative Treatments and Therapies (PR Newswire)
08.03.17	Dope Magazine Features Medical Marijuana, Inc. Subsidiary HempMeds® Mexico In Historic 'Look At America's Reverse-Cannabis Pipeline' (PR Newswire)
07.03.17	Medical Marijuana, Inc. Investment AXIM® Biotech annonce que les patients inscrits entament la phase 2 de l'etude pour le traitement du syndrome du colon irritable (SCI) avec le chewing-gum CanChew... (PR Newswire)
07.03.17	Medical Marijuana, Inc.'s Investmentgesellschaft AXIM® Biotech verkündet Beginn der Phase-II-Studie mit rekrutierten Patienten zur Behandlung des Reizdarmsyndroms (RDS) mit CanChew Plus®... (PR Newswire)
07.03.17	Medical Marijuana, Inc. Investment AXIM® Biotech Announces Enrolled Patients Begin Phase II Trial For The Treatment Of Irritable Bowel Syndrome (IBS) With CanChew Plus® Cannabidiol (CBD) Chewing Gum (PR Newswire)
07.03.17	Medical Marijuana, Inc. Investment AXIM® Biotech Announces Enrolled Patients Begin Phase II Trial For The Treatment Of Irritable Bowel Syndrome (IBS) With CanChew Plus® Cannabidiol (CBD) Chewing Gum (PR Newswire)
06.03.17	Medical Marijuana, Inc. CEO Featured Speaker at California Cannabis Business Expo, Change.org Petition Seeks to Engage Trump Administration (PR Newswire)
01.03.17	'Greater Enforcement' of Federal Laws Would Have Mixed Impact in Cannabis Industry (PR Newswire)
28.02.17	Medical Marijuana, Inc. CEO Covered by National Mexico Media Outlets Discussing Landmark Firsts, CBD Market at A4M Mexico (PR Newswire)
28.02.17	Cannabis CBD Infused Products Grow in Popularity Along With Newest Medicinal Applications and Uses (PR Newswire)
28.02.17	Cannabis CBD Infused Products Grow in Popularity Along With Newest Medicinal Applications and Uses (PR Newswire)
23.02.17	Cannabis Products are Becoming More Acceptable (PR Newswire)
22.02.17	The Tangential Opportunities of the Cannabis Industry (PR Newswire)
21.02.17	Multiple Sclerosis Approval: Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Receives Brazilian Government Permission for Import of Flagship Product RSHO™ (PR Newswire)
21.02.17	FinancialBuzz.com: Cannabis Market Brings in Significant Tax Revenues (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	51.86	1.25 %	K V
Swiss Life Hldg	773.00	1.18 %	K V
Lonza Grp	601.80	1.07 %	K V
UBS Group	30.43	0.83 %	K V
Zurich Insur Gr	567.80	0.78 %	K V
Logitech Intl	94.18	-0.19 %	K V
Givaudan	4’042.00	-0.42 %	K V
Sika	240.20	-0.78 %	K V
Swisscom	495.80	-0.80 %	K V
Sonova Hldg	299.00	-1.19 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Medical Marijuana Inc.

Aktien Top/Flop

Meistgelesene Nachrichten